1: Scaringi C, Minniti G, Caporello P, Enrici RM. Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results. Anticancer Res. 2012 Oct;32(10):4213-23. Review. PubMed PMID: 23060541.
2: Kurozumi K, Ichikawa T, Onishi M, Fujii K, Date I. Cilengitide treatment for malignant glioma: current status and future direction. Neurol Med Chir (Tokyo). 2012;52(8):539-47. Review. PubMed PMID: 22976135.
3: Lombardi G, Zustovich F, Farina P, Polo V, Farina M, Puppa AD, Bertorelle R, Gardiman MP, Berti F, Zagonel V. Cilengitide in bevacizumab-refractory high-grade glioma: two case reports and critical review of the literature. Anticancer Drugs. 2012 Aug;23(7):749-53. doi: 10.1097/CAD.0b013e3283520e2c. Review. PubMed PMID: 22382388.